Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:IHENYSEARCA:IHFNYSEARCA:LABUNASDAQ:PPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIHEiShares U.S. Pharmaceuticals ETF$63.60+0.2%$65.47$58.97▼$73.28$550.14M0.5970,864 shs63,820 shsIHFiShares U.S. Healthcare Providers ETF$46.20-0.5%$50.81$44.62▼$58.94$628.32M0.74151,471 shs319,818 shsLABUDirexion Daily S&P Biotech Bull 3x Shares$50.47-0.8%$54.28$32.55▼$152.60$525.90M2.721.45 million shs977,532 shsPPHVanEck Pharmaceutical ETF$86.30+0.1%$86.45$77.67▼$99.51$620.50M0.72238,500 shs148,303 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIHEiShares U.S. Pharmaceuticals ETF+0.17%-1.90%-1.96%-11.10%-4.56%IHFiShares U.S. Healthcare Providers ETF-0.47%-3.83%-7.34%-8.22%-13.69%LABUDirexion Daily S&P Biotech Bull 3x Shares-0.77%-0.51%-4.38%-44.65%-56.38%PPHVanEck Pharmaceutical ETF+0.14%+0.23%+1.67%-5.44%-4.91%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationIHEiShares U.S. Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AN/AN/AIHFiShares U.S. Healthcare Providers ETFN/AN/AN/AN/AN/AN/AN/AN/ALABUDirexion Daily S&P Biotech Bull 3x SharesN/AN/AN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIHEiShares U.S. Pharmaceuticals ETF 2.66Moderate Buy$63.60N/AIHFiShares U.S. Healthcare Providers ETF 2.71Moderate Buy$46.20N/ALABUDirexion Daily S&P Biotech Bull 3x Shares 2.75Moderate Buy$50.47N/APPHVanEck Pharmaceutical ETF 2.69Moderate Buy$86.30N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIHEiShares U.S. Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AIHFiShares U.S. Healthcare Providers ETFN/AN/AN/AN/AN/AN/ALABUDirexion Daily S&P Biotech Bull 3x SharesN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIHEiShares U.S. Pharmaceuticals ETFN/AN/A22.74∞N/AN/AN/AN/AN/AIHFiShares U.S. Healthcare Providers ETFN/AN/A19.54∞N/AN/AN/AN/AN/ALABUDirexion Daily S&P Biotech Bull 3x SharesN/AN/A0.00∞N/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/A24.60∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIHEiShares U.S. Pharmaceuticals ETF$1.161.82%N/AN/AN/AIHFiShares U.S. Healthcare Providers ETF$0.410.89%N/AN/AN/ALABUDirexion Daily S&P Biotech Bull 3x Shares$0.260.52%N/AN/AN/APPHVanEck Pharmaceutical ETF$1.701.97%N/AN/AN/ALatest LABU, IHE, PPH, and IHF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/31/2025PPHVanEck Pharmaceutical ETFQuarterly$0.52452.36%4/1/20254/1/20254/4/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIHEiShares U.S. Pharmaceuticals ETFN/AIHFiShares U.S. Healthcare Providers ETFN/ALABUDirexion Daily S&P Biotech Bull 3x SharesN/APPHVanEck Pharmaceutical ETFN/AInsider OwnershipCompanyInsider OwnershipIHEiShares U.S. Pharmaceuticals ETFN/AIHFiShares U.S. Healthcare Providers ETFN/ALABUDirexion Daily S&P Biotech Bull 3x SharesN/APPHVanEck Pharmaceutical ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIHEiShares U.S. Pharmaceuticals ETFN/A8.65 millionN/ANot OptionableIHFiShares U.S. Healthcare Providers ETFN/A13.60 millionN/ANot OptionableLABUDirexion Daily S&P Biotech Bull 3x SharesN/A10.42 millionN/ANot OptionablePPHVanEck Pharmaceutical ETF147,0007.19 millionN/AOptionableLABU, IHE, PPH, and IHF HeadlinesRecent News About These CompaniesShould You Invest in the VanEck Pharmaceutical ETF (PPH)?May 21 at 7:20 AM | zacks.comPPH, Big Pharma Stocks Volatile on Trump Drug PricingMay 14, 2025 | finance.yahoo.comETFs on the Move Post U.S.-China Trade DealMay 12, 2025 | zacks.comA Look at Pharma ETFs After Strong Q1 EarningsMay 8, 2025 | zacks.comPPH: Will Overcome Tariffs, But Competitor Funds Look StrongerApril 14, 2025 | seekingalpha.comBig Pharma higher after tariff exemption despite ongoing uncertaintiesApril 3, 2025 | msn.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?March 20, 2025 | zacks.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?January 16, 2025 | zacks.com(PPH) Investment ReportJanuary 6, 2025 | news.stocktradersdaily.comVanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.4110December 27, 2024 | msn.comPPH Is a Pertinent Healthcare Idea for 2025December 19, 2024 | etftrends.com(PPH) Pivots Trading Plans and Risk ControlsDecember 16, 2024 | news.stocktradersdaily.comWhen the Price of (PPH) Talks, People ListenDecember 6, 2024 | news.stocktradersdaily.comShould You Invest in the VanEck Pharmaceutical ETF (PPH)?November 11, 2024 | zacks.comThe Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNROctober 17, 2024 | finance.yahoo.comDiversified Exposure To The Weight Loss Drug MarketOctober 10, 2024 | seekingalpha.comPharma Stocks Losing Ground After A Remarkable Rally, Downgrading PPHOctober 3, 2024 | seekingalpha.comHealthcare ETFs Starting to Look HealthyOctober 1, 2024 | etftrends.comAbbVie stock analysis: Rinvoq and Skyrizi are big catalystsOctober 1, 2024 | msn.comDoubleLine's Jeff Gundlach on the Fed, Gold and Private CreditSeptember 23, 2024 | etftrends.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLABU, IHE, PPH, and IHF Company DescriptionsiShares U.S. Pharmaceuticals ETF NYSEARCA:IHE$63.60 +0.11 (+0.17%) As of 05/23/2025 04:10 PM EasterniShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors.iShares U.S. Healthcare Providers ETF NYSEARCA:IHF$46.20 -0.22 (-0.47%) As of 05/23/2025 04:10 PM EasternThe iShares U.S. Healthcare Providers ETF (IHF) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a cap-weighted index of US companies that provide healthcare services. IHF was launched on May 1, 2006 and is managed by BlackRock.Direxion Daily S&P Biotech Bull 3x Shares NYSEARCA:LABU$50.47 -0.39 (-0.77%) Closing price 05/23/2025 04:10 PM EasternExtended Trading$50.41 -0.06 (-0.12%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.VanEck Pharmaceutical ETF NASDAQ:PPH$86.30 +0.12 (+0.14%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$86.61 +0.31 (+0.36%) As of 05/23/2025 05:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Advance Auto Parts Jumps on Surprise Earnings Beat Costco Stock at $1K: Dominance or Danger Zone? Williams-Sonoma: A Fundamentally Good Buy On Sale Now Snowflake Breaks Out! Can It Drift Higher in 2025 and Beyond? Alphabet Gets JPMorgan’s Vote of Confidence After Google I/O Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
